We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Low-density lipoprotein cholesterol reduction with immediate combination therapy of statin and ezetimibe compared to statin monotherapy after percutaneous coronary intervention

    Background

    Current guidelines recommend a stepwise initiation of lipid-lowering therapy after percutaneous coronary interventions (PCI) in...

    Achim Leo Burger, Nora Beran, ... Kurt Huber in Wiener klinische Wochenschrift
    Article 24 October 2023
  2. Comparative Safety and Efficacy of Low/Moderate-Intensity Statin plus Ezetimibe Combination Therapy vs. High-Intensity Statin Monotherapy in Patients with Atherosclerotic Cardiovascular Disease: An Updated Meta-Analysis

    Aim

    Statin therapy is considered the gold standard for treating hypercholesterolemia. This updated meta-analysis aims to compare the efficacy and...

    Ishaque Hameed, Syeda Ayesha Shah, ... Mohammad Hamza in American Journal of Cardiovascular Drugs
    Article 05 April 2024
  3. Statin therapy improves outcomes in infective endocarditis: evidence from a meta-analysis

    Background

    Beyond its ability to decrease cholesterol, statin medication has been proved to have a variety of pleiotropic effects, such as...

    Mojtaba Hedayat Yaghoobi, Ehsan Heidari, ... Mahmood Bakhtiyari in The Egyptian Heart Journal
    Article Open access 07 June 2024
  4. Effect of statin therapy patterns on readmission and mortality in patients with intracerebral hemorrhage

    There is limited and inconsistent evidence for the association of statin therapy and statin treatment patterns with the risk of recurrent...

    Ruotong Yang, Junhui Wu, ... Yonghua Hu in Journal of Thrombosis and Thrombolysis
    Article 18 September 2023
  5. Strategies aiming to improve statin therapy adherence in older adults: a systematic review

    Background

    Randomized clinical trials have shown that, under optimal conditions, statins reduce the risk of cardiovascular events in older adults....

    Philipp Frieden, Rose Gagnon, ... Jason Robert Guertin in BMC Geriatrics
    Article Open access 21 May 2024
  6. Risk and effect modifiers for poor glycemic control among the chinese diabetic adults on statin therapy: the kailuan study

    Background

    Limited studies have investigated the association between statin therapy and poor glycemic control, especially in the Chinese diabetic...

    Zhaogui Wu, Shuohua Chen, ... **n Zhou in Clinical Research in Cardiology
    Article 24 January 2024
  7. Updates on Non-Statin LDL-Lowering Therapy

    Purpose of Review

    There is ample evidence of the benefits and safety of low-density lipoprotein (LDL)-lowering therapies in the prevention of...

    Amer Abdulla, Mostafa Shalaby, ... Tareq Abu Sharifeh in Current Cardiology Reports
    Article 04 March 2024
  8. Association of statin use after renal replacement therapy with mortality in patients with dialysis-requiring acute kidney injury

    Background

    Statin use before hospitalization or after discharge increased the survival rates of patients with dialysis-requiring acute kidney injury....

    Hsin-Hsiung Chang, Wen-Chih Liu, Tsung-Chang Tsai in International Urology and Nephrology
    Article 17 July 2023
  9. Association of statin therapy with progression of carotid arterial stiffness: the Multi-Ethnic Study of Atherosclerosis (MESA)

    Arterial stiffness progresses with age and is a predictor of adverse cardiovascular disease events. Studies examining associations of statin therapy...

    Anatoliy Nechyporenko, Yacob G. Tedla, ... Adam D. Gepner in Hypertension Research
    Article 25 November 2022
  10. A mobile health application for patients eligible for statin therapy: app development and qualitative feedback on design and usability

    Background

    Cardiovascular disease is the leading cause of death in the United States (US). Despite the well-recognized efficacy of statins, statin...

    Weidan Cao, Lang Li, ... M. Wesley Milks in BMC Medical Informatics and Decision Making
    Article Open access 19 July 2023
  11. Endothelin-1 is associated with mortality that can be attenuated with high intensity statin therapy in patients with stable coronary artery disease

    Background

    All coronary artery disease (CAD) patients do not benefit equally of secondary prevention. Individualized intensity of drug therapy is...

    Ruizhu Lin, Juhani Junttila, ... Risto Kerkelä in Communications Medicine
    Article Open access 22 June 2023
  12. Statin Intolerance: an Overview of US and International Guidance

    Purpose of Review

    To review recent international and domestic definitions, considerations, and treatment algorithms for statin intolerance, and...

    Mary Katherine Cheeley, Katarina Clegg, ... Laney K. Jones in Current Atherosclerosis Reports
    Article Open access 06 July 2023
  13. The Role of Mitochondria in Statin-Induced Myopathy

    Statins represent the primary therapy for combatting hypercholesterolemia and reducing mortality from cardiovascular events. Despite their...

    Gavin Bell, Anastasia Thoma, ... Adam P. Lightfoot in Drug Safety
    Article 16 March 2024
  14. Association between circulatory microRNA-218 expression, serum PCSK9 levels, inflammatory markers, and monocyte subsets in coronary artery disease patients: impact of statin therapy

    Background

    Proprotein convertase subtilisin/kexin type-9 (PCSK9), an enzyme produced mainly by hepatocytes and breaks low-density lipoprotein receptor...

    Dina A. Desouky, Nahla A. Nosair, ... Mohamed K. Salama in Beni-Suef University Journal of Basic and Applied Sciences
    Article Open access 06 June 2024
  15. Effect of an increase in Lp(a) following statin therapy on cardiovascular prognosis in secondary prevention population of coronary artery disease

    Background

    Lipoprotein (a) [Lp(a)] is an independent risk factor for coronary artery disease (CAD). Recent studies have indicated that statins tend to...

    Lijun Zhu, Yangliang Fang, ... **yu Huang in BMC Cardiovascular Disorders
    Article Open access 08 November 2022
  16. Relative contributions of statin intensity, achieved low-density lipoprotein cholesterol level, and statin therapy duration to cardiovascular risk reduction in patients with type 2 diabetes: population based cohort study

    Background

    Current guidelines recommend life-long use of statin for patients with type 2 diabetes (T2D), however, a number of patients discontinue...

    Ji Yoon Kim, Jimi Choi, ... Nam Hoon Kim in Cardiovascular Diabetology
    Article Open access 22 February 2022
  17. Safety of Combined Statin and Fibrate Therapy: Risks of Liver Injury and Acute Kidney Injury in a Cohort Study from the Shizuoka Kokuho Database

    Introduction

    Statins and fibrates are important means of preventing cardiovascular diseases, particularly when administered in combination as part of...

    Yohei Sobukawa, Taichi Hatta, ... Eiji Nakatani in Drugs - Real World Outcomes
    Article Open access 10 May 2024
  18. Early Management of Blood Lipid Levels with Non-Statin Lipid-Lowering Drugs in Acute Coronary Syndrome: A Mini Review

    Acute coronary syndrome (ACS) remains a major cause of morbidity and mortality, despite many improvements in its prevention and management. Lipid...

    Chen Chen, Fang-Fei Wei, ... Chen Liu in Cardiovascular Drugs and Therapy
    Article 29 June 2024
  19. The effect of a multi-component behavior change technique intervention on medication adherence among individuals on primary prevention statin therapy: a dose-finding protocol

    Background

    In the USA, the primary cause of death and morbidity continues to be cardiovascular disease (CVD). Numerous trials have shown that statin...

    Mark J. Butler, Anne-Marie N. Romain, ... Karina W. Davidson in Trials
    Article Open access 12 August 2023
  20. Factors Associated with Discontinuation of Statin Therapy in Patients with Lymphoma Aged 80 Years and Older: A Retrospective Single-Institute Study

    Background

    There is little evidence to support or negate the benefits of statin therapy for primary prevention of cardiovascular disease (CVD) in...

    Satoshi Yamasaki, Tomotake Tokunou, Takahiko Horiuchi in Drugs - Real World Outcomes
    Article Open access 18 June 2022
Did you find what you were looking for? Share feedback.